Abstract
Reports from China and South Korea have shown improvements in critically ill Covid-19 patients using convalescent plasma from recovered individuals. On 25 March 2020, the Food and Drug Administration announced convalescent plasma guidelines for Covid-19 patients. We collected plasma from one donor by a novel donation method that could safely provide plasma sufficient to 10 patients. Four critically ill patients received convalescent plasma and had well-recognized clinical improvements in 12 to 72 hours. To our knowledge, we are the first to report this novel convalescent plasma collection method. In the view of lack of enough donors, this method can be a breakthrough in the treatment of such a rapidly spreading illness.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: ARID International Journal for Science and Technology
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
